New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans In Vitro and In Vivo

Authors:

Abstract
In the past decades, the incidence of cryptococcosis has increased dramatically, which poses a new threat to human health. However, only a few drugs are available for the treatment of cryptococcosis. Here, we described a leading compound, NT-a9, an analogue of isavuconazole, that showed strong antifungal activities in vitro and in vivo .
Funding Information
  • Natural Science Foundation of Shanghai Municipality (17ZR1437700)
  • National Natural Science Foundation of China (81573473)
  • National Natural Science Foundation of China (81830106, 81673280)

This publication has 29 references indexed in Scilit: